Papillary renal cell carcinoma

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

3 events
Mar 2023Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial

National Cancer Institute (NCI) — PHASE2

TrialACTIVE NOT RECRUITING
Jun 2022Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC

Centre Leon Berard — PHASE2

TrialRECRUITING
Oct 2021Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

AstraZeneca — PHASE3

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Papillary renal cell carcinoma.
Check the disease page for updates →

Clinical Trial Landscape

3 active trials
1Phase 3
2Phase 2
3Total recruiting
Search clinical trials for Papillary renal cell carcinoma

Recent News & Research

No recent news articles indexed yet for Papillary renal cell carcinoma.
Search PubMed for Papillary renal cell carcinoma

Browse all Papillary renal cell carcinoma news →

Specialist Network

Top 6 by expertise

View all Papillary renal cell carcinoma specialists →

Quick Actions